BRIXMOR (BRX) Form 144 Filed for 2,000-Share Insider Sale on NYSE

Rhea-AI Filing Summary

Form 144 notice reports a proposed sale of 2,000 shares of Common stock with an aggregate market value of $51,480 and approximately 306,099,542 shares outstanding. The approximate date of sale is 07/17/2025 on the NYSE and the listed broker is THE CHARLES SCHWAB CORPORATION at 3000 Schwab Way Westlake TX 76262.

The filing discloses acquisition details for the securities to be sold: grants received as compensation on 04/27/2022 (4,671 shares), 04/26/2023 (5,885 shares), and 04/25/2024 (5,512 shares). The filer reports no securities sold in the past three months and includes the required representation regarding material nonpublic information and trading-plan disclosure language.

Positive

• Sale specifics disclosed: number of shares (2,000), aggregate value ($51,480), approximate sale date (07/17/2025), and exchange (NYSE)
• Acquisition history provided: grants dated 04/27/2022 (4,671), 04/26/2023 (5,885), and 04/25/2024 (5,512) listed as compensation
• No recent dispositions: filer reports nothing sold in the past three months, indicating this is not part of an ongoing rapid sell-down
• Required attestation present: representation regarding material nonpublic information and Rule 10b5-1/trading-plan language included

Negative

• Missing filer identifiers in provided excerpt: filer CIK/CCC and submission contact fields appear blank in the content shown
• Issuer header fields incomplete: issuer name, SEC file number, address and phone are not populated in the provided tables
• Potential procedural concern if originals lack identifiers: absence of clear filer and issuer identification in the excerpt could hinder traceability

Insights

Financial Analyst

TL;DR: Routine insider sale notice for 2,000 shares, limited financial impact given size versus ~306M outstanding shares.

The Form 144 documents a proposed sale of 2,000 common shares valued at $51,480 against an issuer base of 306,099,542 shares outstanding, implying an immaterial dilution or market impact from this specific sale. Acquisition history shows the shares arose from compensation grants over three consecutive years, confirming this is an insider disposition of previously awarded equity rather than a primary issuance. The filing also reports no sales in the prior three months, which supports the characterization of this as an isolated disposition. Overall, the disclosure is consistent with routine Section 144 compliance and does not present material financial information for investors.

Corporate Governance Expert

TL;DR: Compliance-focused filing that meets basic Rule 144 disclosure but omits some issuer/filer identifying fields in the presented excerpt.

The document includes the mandatory representations regarding lack of material nonpublic information and the signature/attestation language, fulfilling key governance and legal attestations for a Rule 144 sale. Acquisition entries identify compensation grants and dates, which aids traceability of insider holdings. However, the provided content excerpt lacks explicit filer CIK/CCC and full issuer header details in the issuer section as presented here; if truly missing from the filed form, that would be a procedural deficiency. As presented, the filing otherwise documents the sale particulars required for market transparency.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	THE CHARLES SCHWAB CORPORATION 3000 Schwab Way Westlake TX 76262	2000	51480	306099542	07/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/27/2022	Grant	Issuer			4671	04/27/2022	Compensation
Common	04/26/2023	Grant	Issuer			5885	04/26/2023	Compensation
Common	04/25/2024	Grant	Issuer			5512	04/25/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does BRX's Form 144 report?

The Form 144 reports a proposed sale of 2,000 common shares valued at $51,480, with an approximate sale date of 07/17/2025 on the NYSE.

How many shares does BRX have outstanding according to the filing?

The filing lists 306,099,542 shares outstanding.

Were the shares to be sold acquired through purchase or compensation?

The shares were acquired as grants for compensation on 04/27/2022 (4,671), 04/26/2023 (5,885), and 04/25/2024 (5,512).

Has the filer sold other BRX securities in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Who is the broker named in the Form 144?

The broker listed is THE CHARLES SCHWAB CORPORATION, 3000 Schwab Way Westlake TX 76262.